GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaEssentia Corp (TPE:6446) » Definitions » Investments And Advances

PharmaEssentia (TPE:6446) Investments And Advances : NT$0 Mil (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is PharmaEssentia Investments And Advances?

PharmaEssentia's Investments And Advances for the quarter that ended in Mar. 2025 was NT$0 Mil.


PharmaEssentia Investments And Advances Historical Data

The historical data trend for PharmaEssentia's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaEssentia Investments And Advances Chart

PharmaEssentia Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PharmaEssentia Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaEssentia Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


PharmaEssentia Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 2nd Floor, No. 5, Nangang District, Taipei, TWN, 115
PharmaEssentia Corp is engaged in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug pattern developments. It focuses on Hematology, Oncology, and Infectious Diseases. The company derives its revenue from the sales of medicine products. Geographically, the company generates maximum revenue from America, followed by Europe, Asia (excluding Taiwan), and Taiwan.

PharmaEssentia Headlines

No Headlines